alexa Cardiovascular Risk in People Living with HIV/AIDS: Implications for Health Care | OMICS International
ISSN 2155-6113
Journal of AIDS & Clinical Research

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Cardiovascular Risk in People Living with HIV/AIDS: Implications for Health Care

Renata Karina Reis* and Elizabete Santos Melo

College of Nursing, University of São Paulo, WHO Collaborating Centre for Nursing Research Development Postgraduate Program in Fundamental Nursing Ribeirão Preto SP, Brazil

*Corresponding Author:
Renata Karina Reis
College of Nursing
University of SãoPaulo
Ribeirão Preto, SP, Brazil
Tel: +55-16-3315-34-21
E-mail: [email protected]

Received date: September 26, 2015; Accepted date: October 16, 2015; Published date: October 25, 2015

Citation: Reis RK, Melo ES (2015) Cardiovascular Risk in People Living with HIV/ AIDS: Implications for Health Care. J AIDS Clin Res 6:513. doi:10.4172/2155- 6113.1000513

Copyright: © 2015 Reis RK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of AIDS & Clinical Research

In the past 30 years, medical advances for those with human immunodeficiency virus (HIV) have reduced morbidity and mortality to extend life with the continued development of new therapies [1]. The introduction of Highly Active Antiretroviral Therapy (HAART) has resulted in a more effective infection control, immunity restoration and reduction of morbidity and mortality, transforming AIDS into a chronic disease.

Such advances, however, are now faced with new challenges, among them stand out the need to expand access to ART and improve adherence to this therapy and control the undesirable effects of this therapy, and the need to prevent, recognize and manage emerging comorbidities that in the pre-antiretroviral therapy (HAART), had no great expression [2].

With this new paradigm, in recent years the cardiovascular risk of people living with HIV/aids has become the focus of researchers studies in different regions and levels of development [3-8]. The presence of other co-morbidities such as hypertension, diabetes, dyslipidemia and obesity, is also common in this population, thereby increasing the risk for developing cardiovascular diseases [9,10] which have emerged as an important cause of morbidity and mortality in adults living with HIV/AIDS [7].

The evidence demonstrated by cohort studies have shown that people living with HIV are at risk for cardiovascular diseases 1.5 to 2 times higher than the general Population [11,12].

The traditional paradigm to explain this increased risk includes the effect of HIV infection itself, since they have persistent immune and inflammatory activation, and the effects of antiretroviral therapy, which causes dyslipidemia, ectopic fat accumulation (lipodystrophy) and diabetes or insulin resistance. As well as factors such as smoking, coinfection and drug use. Once such factors contribute to the formation of calcified coronary plaques [7,13].

Thus, the study of Van Vonderen et al. showed that people living with HIV/aids have a higher prevalence and degree of premature coronary atherosclerosis compared to the general population. Similarly, cross-sectional studies have shown that HIV-infected individuals have provided significant risk for acute myocardial infarction (AMI), according to the Framingham scores [7,14].

Taken together, these data suggest a new mechanistic paradigma for atherogenesis in HIV disease, and potential strategies for reducing inflammation and atherosclerosis [13]. These strategies would minimize the classic risk factors such as smoking cessation, blood pressure control, correction of insulin resistance and dyslipidemia, obesity reduction and use of less-toxic antiretroviral therapy. Viral burden and latency can be reduced through earlier initiation of antiretroviral therapy and use of intensification strategies [13].

Currently, HIV/aids is considered a chronic condition and is associated with increased risk of 50% of acute myocardial infarction in addition to the recognized risk factors [12] which may have impact on morbidity and mortality of these individuals. By the time discussing the importance of early antiretroviral therapy for people living with HIV/ aids is important not to lose sight of the impact of increased longevity of these individuals in pursuit of development and implementation of public policies to modify a setting that has sociocultural factors which lead to excessive consumption of foods high in calories by population, physical inactivity and, consequently, the development of obesity and diabetes associated with excess dietary salt. These factors contribute to the occurrence of hypertension and are decisive for the high prevalence of CVD [15].

In addition, the recognition of cardiovascular risk factors among people living with HIV/aids can contribute to the organization of health services in the sense that they have the opportunity to seek interventions aimed at the prevention of CVD through orientation lifestyle changes.

Despite this scenario few studies in Brazil have been conducted to evaluate the risk factors of these individuals.

These indicators point to the need for studies that contribute to the implementation of interventions for the prevention and treatment of cardiovascular risk factors in people living with HIV/aids, as these require interdisciplinary care. In addition, the results may contribute also to structure and strengthen the urgency and emergency care of these individuals in the network of health care.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • 6th World Congress on Control and Prevention of HIV/AIDS , STDs & STIs
    August 27-29, 2018 Zurich, Switzerland
  • 6th International Conference on HIV/AIDS , STDs and STIs
    October 29-30, 2018 San Francisco, USA

Article Usage

  • Total views: 11783
  • [From(publication date):
    October-2015 - Jul 18, 2018]
  • Breakdown by view type
  • HTML page views : 8000
  • PDF downloads : 3783

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7